Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harten

Showing results (1-10 of 863) with videos related to

Pageof 87
Sort By:
Zeitschrift Fur Rheumatologie|October 10, 2007
[Fibromyalgia syndrome: new developments in pharmacotherapy]P Harten
Zeitschrift Fur Rheumatologie|June 21, 2005
[Reducing toxicity of methotrexate with folic acid]P Harten
Clinical Pharmacokinetics|March 1, 1993
Clinical pharmacokinetics of selective serotonin reuptake inhibitorsJ van Harten
Occupational Medicine (Philadelphia, Pa.)|February 27, 1998
Functional capacity evaluationJ A Harten
Clinical Pharmacokinetics|January 1, 1995
Overview of the pharmacokinetics of fluvoxamineJ van Harten
Evidence-Based Dentistry|March 30, 2020
Do socio-economic circumstances affect oral health related quality of life?Maria van Harten
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2002
[Drug-induced akathisia]P N van Harten
Australian and New Zealand Journal of Public Health|July 6, 2004
Patterns of active transport in 11-12 year old Australian childrenNathan Harten, Tim Olds
Biochemistry|May 17, 1988
Properties of thrombin- and elastase-modified human antithrombin IIIP Gettins, B Harten
Tijdschrift Voor Psychiatrie|June 13, 2008
[Number needed to treat: a useful tool for estimating the effectiveness of a treatment]P N van Harten
Pageof 87

Showing results (1-10 of 863) with videos related to

Sort By:
Pageof 87
Zeitschrift Fur Rheumatologie|October 10, 2007
[Fibromyalgia syndrome: new developments in pharmacotherapy]P Harten
Zeitschrift Fur Rheumatologie|June 21, 2005
[Reducing toxicity of methotrexate with folic acid]P Harten
Clinical Pharmacokinetics|March 1, 1993
Clinical pharmacokinetics of selective serotonin reuptake inhibitorsJ van Harten
Occupational Medicine (Philadelphia, Pa.)|February 27, 1998
Functional capacity evaluationJ A Harten
Clinical Pharmacokinetics|January 1, 1995
Overview of the pharmacokinetics of fluvoxamineJ van Harten
Evidence-Based Dentistry|March 30, 2020
Do socio-economic circumstances affect oral health related quality of life?Maria van Harten
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2002
[Drug-induced akathisia]P N van Harten
Australian and New Zealand Journal of Public Health|July 6, 2004
Patterns of active transport in 11-12 year old Australian childrenNathan Harten, Tim Olds
Biochemistry|May 17, 1988
Properties of thrombin- and elastase-modified human antithrombin IIIP Gettins, B Harten
Tijdschrift Voor Psychiatrie|June 13, 2008
[Number needed to treat: a useful tool for estimating the effectiveness of a treatment]P N van Harten
Pageof 87